Baylor College of Medicine: Lifestyle Intervention, Non-Statin Therapies in Patients With Elevated Triglycerides Recommended
July 29, 2021
July 29, 2021
HOUSTON, Texas, July 29 (TNSJou) -- The Baylor College of Medicine issued the following news:
New clinical guidance from the American College of Cardiology recommends the addition of lifestyle intervention and/or pharmacological, non-statin management of those high-risk patients with persistent abnormal levels of elevated triglycerides known as hypertriglyceridemia, who are on lipid-lowering medications. The writing committee for this 2021 Expert Consensus Decision Pathway is made u . . .
New clinical guidance from the American College of Cardiology recommends the addition of lifestyle intervention and/or pharmacological, non-statin management of those high-risk patients with persistent abnormal levels of elevated triglycerides known as hypertriglyceridemia, who are on lipid-lowering medications. The writing committee for this 2021 Expert Consensus Decision Pathway is made u . . .